7210 Wareham Drive, Tampa, FL 33647
Feb. 28, 2024 WW reported its results for Q4 2023 and the full year today. WW reported results in line with analysts’ expectations in Q4 FY2023, with revenue down 8% year on year to $206 million. “2023 was a pivotal year as we began transforming our business for the future. We returned WeightWatchers to year […]
Weight Watchers Reports Q4 and 2023 Results Read More »
January 4, 2024 The history of weight loss drugs in the U.S. is filled with meds that were taken off the market due to nasty side effects, going back to the phen/fen crisis of 1997. Many more followed (Belviq, Qsymia, Taranabant, Acomplia) . These side effects did not emerge until years after entering the market
Semaglutide Boom – The Beginning of a Decline? New FDA Report Read More »
Nov. 7, 2023 Management stated: “Medically-supported weight loss solutions have brought a fresh focus to the landscape, and it’s important that we continue to develop an approach that recognizes the needs of the customers who choose to utilize medication as part of their health and wellness journey as we broaden our offerings, expand our addressable
Medifast Reports Q3 Results Read More »
November 2, 2023 WW reported results for its 3rd quarter. Management reported that: “We have successfully returned WeightWatchers to subscriber growth, with Q3 end of period subscribers up 6% year-over-year to 4.0 million. This is a significant achievement and a direct result of our work in reinvigorating our core product,” said Sima Sistani, the company’s
Weight Watchers Reports 3rd Quarter Results Read More »
Sept. 27, 2023 Jenny Craig, a Wellful Inc., brand, has re-launched as a direct-to-consumer platform. The intermittent fasting focused, weight loss brand is now available for home delivery. In addition to home delivery service, consumers also may schedule appointments with weight loss coaches online. In July, Wellful acquired Jenny at an undisclosed amount after the
Jenny Craig Relaunches – Now Delivering Meals Online Read More »
Sept. 13, 2023 On August 8, Lilly reported that its second-quarter income jumped 85% from the same period a year ago, driven in large part by Mounjaro, which generated $979.7 million in sales for the quarter, compared to $16 million in the year-ago period and $569 million in the first quarter of this year. In
Obesity Drug Sales Continue To Soar Read More »
Aug. 8, 2023 Second quarter 2023 revenue decreased 34.7% to $296.2 million from $453.3 million for the second quarter of 2022, primarily driven by a decrease in the number of active earning OPTAVIA Coaches and the decline in the productivity per active earning OPTAVIA Coach. The average revenue per active earning OPTAVIA Coach was $5,578, compared to $6,667 for the second quarter last year, a
Medifast Reports Q2 Results Read More »
Aug. 5, 2023 WW reported its second quarter results yesterday. End of Period Subscribers of 4.1 million Revenues of $226.8 million Operating Income of $26.3 million; excluding the net impact of restructuring charges and acquisition transaction costs, adjusted operating income of $33.9 million Full Year Fiscal 2023 Guidance: Revenues are expected to be in the
Weight Watchers Reports 2nd Quarter 2023 Results Read More »
March 7, 2021 Marketdata’s research to update its study: “The U.S. Weight Loss & Diet Control Market” continues. One of the key chapters in this upcoming report tracks the meal replacements (powdered shakes, nutrition bars) and appetite suppressants market (retail and MLM non-prescription diet pills). Meal replacements have done well in 2020. Diet pills, not
Meal Replacements Do Well During The Pandemic Read More »
Feb. 10, 2021 Marketdata is now updating its largest, best-selling biennial report: “The U.S. Weight Loss & Diet Control Market”, due to be released in 3-4 weeks. Research so far has uncovered a few things about some of the market segments and how they fared in 2020 during the pandemic. One part of the weight
New Weight Loss Market Research Coming – Health Clubs Take A Beating in 2020 Read More »